These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18095166)

  • 1. Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression.
    Walkup J; Wei W; Sambamoorthi U; Crystal S
    Psychiatr Q; 2008 Mar; 79(1):43-53. PubMed ID: 18095166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya.
    Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ
    J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antidepressant treatment on antiretroviral regimen adherence among depressed HIV-infected patients.
    Kumar V; Encinosa W
    Psychiatr Q; 2009 Sep; 80(3):131-41. PubMed ID: 19387832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients.
    Dalessandro M; Conti CM; Gambi F; Falasca K; Doyle R; Conti P; Caciagli F; Fulcheri M; Vecchiet J
    J Clin Psychopharmacol; 2007 Feb; 27(1):58-61. PubMed ID: 17224714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda.
    Abaasa AM; Todd J; Ekoru K; Kalyango JN; Levin J; Odeke E; Karamagi CA
    BMC Health Serv Res; 2008 Nov; 8():241. PubMed ID: 19021908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to highly active antiretroviral therapy in depressed patients with HIV/AIDS attending a Nigerian university teaching hospital clinic.
    Olisah VO; Baiyewu O; Sheikh TL
    Afr J Psychiatry (Johannesbg); 2010 Sep; 13(4):275-9. PubMed ID: 20957326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART.
    Lima VD; Geller J; Bangsberg DR; Patterson TL; Daniel M; Kerr T; Montaner J; Hogg RS
    AIDS; 2007 May; 21(9):1175-83. PubMed ID: 17502728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.
    Robinson RL; Long SR; Chang S; Able S; Baser O; Obenchain RL; Swindle RW
    J Manag Care Pharm; 2006; 12(1):43-54. PubMed ID: 16420107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of antidepressant medications on antiretroviral treatment adherence in HIV-positive individuals with depression.
    El-Halabi S; Cooper DH; Cha DS; Rosenblat JD; Gill B; Rodrigues NB; Lipsitz O; McIntyre RS; Gill H
    J Affect Disord; 2022 Mar; 300():219-225. PubMed ID: 34952118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy?
    Himelhoch S; Moore RD; Treisman G; Gebo KA
    J Acquir Immune Defic Syndr; 2004 Dec; 37(4):1457-63. PubMed ID: 15602123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations of treatment-naive patients with acquired immunodeficiency syndrome and responses to highly active antiretroviral therapy in the Taipei Veterans General Hospital: a 5-year prospective study.
    Hsu SF; Yang SP; Chan YJ; Wang YW
    J Microbiol Immunol Infect; 2011 Jun; 44(3):198-203. PubMed ID: 21524614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression, social support and adherence to highly active antiretroviral therapy in people living with HIV/AIDS.
    Gibbie T; Hay M; Hutchison CW; Mijch A
    Sex Health; 2007 Dec; 4(4):227-32. PubMed ID: 18082064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence.
    Stone VE; Jordan J; Tolson J; Miller R; Pilon T
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):808-16. PubMed ID: 15213564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon.
    Nsagha DS; Weledji EP; Assob NJ; Njunda LA; Tanue EA; Kibu OD; Ayima CW; Ngowe MN
    BMC Cardiovasc Disord; 2015 Aug; 15():95. PubMed ID: 26315756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to Antiretroviral Therapy Among Iranian HIV/AIDS Patients.
    Khalili H; Rohani R; Seyedalinaghi S; Hajiabdolbaghi M; Dashti-Khavidaki S; Talasaz AH
    Curr Clin Pharmacol; 2012 May; 7(2):111-115. PubMed ID: 22432842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.
    Haddad M; Inch C; Glazier RH; Wilkins AL; Urbshott G; Bayoumi A; Rourke S
    Cochrane Database Syst Rev; 2000; (3):CD001442. PubMed ID: 10908497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia.
    Tadios Y; Davey G
    Ethiop Med J; 2006 Jul; 44(3):237-44. PubMed ID: 17447389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.